This is a multicenter, prospective, randomized, double-blind placebo-controlled clinical trial to assess whether methotrexate (MTX) improved the therapeutic efficacy of ursodeoxycholic acid (UCA) in the treatment of patients with Primary Biliary Cirrhosis (PBC).
Showing the most recent 10 out of 343 publications